Safety and efficacy of drug-eluting stents in patients with acute myocardial infarction-From first generation to second generation of drug-eluting stents

Journal of Cardiology

Volumn 61, Issue 5, 2013, Pages 378-379

  Suzuki, Hiroshi ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Acute myocardial infarction; Drug eluting stents; Long term outcome; Sirolimus eluting stents

Indexed keywords

ACETYLSALICYLIC ACID; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; THIENOPYRIDINE DERIVATIVE; UMIROLIMUS; ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANTICOAGULANT THERAPY; BARE METAL STENT; CLINICAL EFFECTIVENESS; DEVICE SAFETY; DRUG ELUTING STENT; EDITORIAL; FOLLOW UP; HEART DEATH; HEART DISEASE; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; INCIDENCE; META ANALYSIS (TOPIC); MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; VASOCONSTRICTION;

DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSTHESIS IMPLANTATION; THROMBOSIS;

EID: 84877628770     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.02.016     Document Type: Editorial

References (15)

1. Stone G.W., Grines C.L., Cox D.A., Garcia E., Tcheng J.E., Griffin J.J., Guagliumi G., Stuckey T., Turco M., Carroll J.D., Rutherford B.D., Lansky A.J. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002, 346:957-966.
2. Spaulding C., Henry P., Teiger E., Beatt K., Bramucci E., Carrié D., Slama M.S., Merkely B., Erglis A., Margheri M., Varenne O., Cebrian A., Stoll H.P., Snead D.B., Bode C. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006, 355:1093-1104.
3. Stone G.W., Lansky A.J., Pocock S.J., Gersh B.J., Dangas G., Wong S.C., Witzenbichler B., Guagliumi G., Peruga J.Z., Brodie B.R., Dudek D., Möckel M., Ochala A., Kellock A., Parise H., et al. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 2009, 360:1946-1959.
4. Brar S.S., Leon M.B., Stone G.W., Mehran R., Moses J.W., Brar S.K., Dangas G. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 2009, 53:1677-1689.
5. Steg P.G., Fox K.A., Eagle K.A., Furman M., Van de Werf F., Montalescot G., Goodman S.G., Avezum A., Huang W., Gore J.M. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J 2009, 30:321-329.
6. Daemen J., Tanimoto S., Garcia-Garcia H.M., Kukreja N., van de Sande M., Sianos G., de Jaegere P.P., van Domburg R.T., Serruys P.W. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH registries). Am J Cardiol 2007, 99:1027-1032.
7. Nakazawa G., Finn A.V., Joner M., Ladich E., Kutys R., Mont E.K., Gold H.K., Burke A.P., Kolodgie F.D., Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study. Circulation 2008, 118:1138-1145.
8. Joner M., Finn A.V., Farb A., Mont E.K., Kolodgie F.D., Ladich E., Kutys R., Skorija K., Gold H.K., Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006, 48:193-202.
9. Nakazawa G., Otsuka F., Nakano M., Vorpahl M., Yazdani S.K., Ladich E., Kolodgie F.D., Finn A.V., Virmani R. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011, 57:1314-1322.
10. Adachi T., Kotani J., Ikari Y., Kyo E., Nakamura M., Yokoi H. The Japanese experience with sirolimus-eluting stent implantation in the infarct-related artery: five years of observation from the J-PMS study. J Cardiol 2013, 61:321-325.
11. Kimura T., Morimoto T., Nakagawa Y., Tamura T., Kadota K., Yasumoto H., Nishikawa H., Hiasa Y., Muramatsu T., Meguro T., Inoue N., Honda H., Hayashi Y., Miyazaki S., Oshima S., et al. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009, 119:987-995.
12. Kawaguchi R., Kimura T., Morimoto T., Oshima S., Hoshizaki H., Kawai K., Kawai K., Shiode N., Hiasa Y., Mitsudo K. Safety and efficacy of sirolimus-eluting stent implantation in patients with acute coronary syndrome in the real world. Am J Cardiol 2010, 106:1550-1560.
13. Kimura T., Isshiki T., Hayashi Y., Oshima S., Namura M., Nakashima H., Kawai K., Sone T., Tatami R., Meguro T., Nobuyoshi M., Mitsudo K. Incidence and outcome of surgical procedures after sirolimus eluting stent implantation: a report from the j-Cypher registry. Cardiovasc Interv Ther 2010, 25:29-39.
14. Sabate M., Cequier A., Iñiguez A., Serra A., Hernandez-Antolin R., Mainar V., Valgimigli M., Tespili M., den Heijer P., Bethencourt A., Vazquez N., Gómez-Hospital J.A., Baz J.A., Martin-Yuste V., van Geuns R.J., et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomized controlled trial. Lancet 2012, 380:1482-1490.
15. Raber L., Kelbæk H., Ostojic M., Baumbach A., Heg D., Tüller D., von Birgelen C., Roffi M., Moschovitis A., Khattab A.A., Wenaweser P., Bonvini R., Pedrazzini G., Kornowski R., Weber K., et al. Effect of biolimus-eluting stents with biodegradable polymer vs. bare-metal stents on cardiovascular events among patients with acute myocardial infarction-the COMFORTABLE AMI randomized trial. JAMA 2012, 308:777-787.